Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | PFKFB3 | Q16875 | 3/20 | 0.53 |
| ▸ | PFKFB4 | Q16877 | 4/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21104597 | 0.83 | SMN1; SMN2 (0.57) | ALDH1A1POLBMEN1KMT2AFABP4 | |
| SCHEMBL21135669 | 0.81 | KMT2A (0.51) | ALDH1A1POLBMEN1KMT2ALMNA | |
| SCHEMBL3559952 | 0.78 | ALDH1A1 (0.51) | WDR5ALDH1A1THRBPOLBMEN1 | |
| SCHEMBL13811849 | 0.78 | ALDH1A1 (0.67) | WDR5ALDH1A1THRBPOLBMEN1 | |
| SCHEMBL11025715 | 0.76 | POLB (0.78) | ALDH1A1THRBPOLBMEN1KMT2A | |
| SCHEMBL27424129 | 0.76 | THRB (0.65) | WDR5ALDH1A1THRBPOLBMEN1 | |
| SCHEMBL31006706 | 0.76 | THRB (0.65) | WDR5ALDH1A1THRBPOLBMEN1 | |
| SCHEMBL894613 | 0.75 | POLB (0.82) | ALDH1A1THRBPOLBMEN1KMT2A | |
| SCHEMBL18900521 | 0.75 | WDR5 (0.57) | WDR5ALDH1A1THRBPOLBMEN1 | |
| SCHEMBL1677059 | 0.75 | ALDH1A1 (0.75) | WDR5ALDH1A1POLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10717706-B2 | M-phenylenediamine compound and method for producing polymer compound using same | FUJIFILM CORPORATION (JP) | 2020-07-21 | — | — | US | disclosed |
| US-20190177270-A1 | NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME | FUJIFILM CORPORATION (JP) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177270-A1 | NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME | PNMT, PRMT9, HRH3 | WDR5 442/4885ALDH1A1 3083/4885THRB 4304/4885 |
| US-10717706-B2 | M-phenylenediamine compound and method for producing polymer compound using same | PNMT, HRH3, PRMT9 | WDR5 793/4885ALDH1A1 3143/4885THRB 4488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.